|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
and ERβ Signaling in a Cell-Type Specific FashionDepartment for Biosciences and Nutrition, Karolinska Institutet at Novum, Huddinge, Sweden (E.S., J.R., M.H.-F., I.P., K.P.); Institut National de la Recherche Agronomique, Unité Mixte de Recherche 1089 Xénobiotiques, Toulouse, France (A.H., D.Z.); and Karo Bio AB, Novum, Huddinge, Sweden (S.R.)
The biological effects of 17β-estradiol (E2) are mediated by the two estrogen receptor (ER) isoforms ER
and ERβ. These receptors are ligand-inducible transcription factors that belong to the nuclear receptor superfamily. These receptors are also targets for a broad range of natural and synthetic compounds that induce ER activity, including dietary compounds, pharmaceuticals, and various types of environmental pollutants such as bisphenols and polychlorinated hydroxy-biphenyls. Here, we study the effect of the combustion byproduct 3-methylcholanthrene (3-MC) on ER
and ERβ. 3-MC is a compound identified previously as an activator of the aryl hydrocarbon receptor (AhR). Activation of AhR is traditionally associated with an inhibition of the E2 signaling network. In this study, we demonstrate that 3-MC is a cell-specific activator or inhibitor of E2 signaling pathways. We show that 3-MC acts as a repressor in some cells, presumably via the AhR, whereas it is a potent activator of ER activity in other cells. It is interesting that we demonstrate that the estrogenic effects of 3-MC are dependent on the ability of cells to metabolize parental 3-MC to alternative compounds. In summary, our results suggest that exposure to AhR ligands like 3-MC can lead to either activation or repression of E2 signaling, depending on the cellular context.
Address correspondence to: Katarina Pettersson, Karolinska Institute, Department for Biosciences and Nutrition, S-141 57 Huddinge, Sweden. E-mail: katarina.pettersson{at}biosci.ki.se
This article has been cited by other articles:
![]() |
E. Swedenborg, J. Ruegg, S. Makela, and I. Pongratz Endocrine disruptive chemicals: mechanisms of action and involvement in metabolic disorders J. Mol. Endocrinol., July 1, 2009; 43(1): 1 - 10. [Abstract] [Full Text] [PDF] |
||||